No abstract available
MeSH terms
-
Antifibrinolytic Agents / therapeutic use
-
Anxiety / prevention & control
-
Arrhythmias, Cardiac / etiology
-
Arrhythmias, Cardiac / therapy
-
Biomedical Research / trends
-
Cardiac Imaging Techniques / methods
-
Cardiomyopathies / etiology
-
Cardiomyopathies / therapy
-
Cardiotonic Agents / therapeutic use
-
Coronary Artery Bypass / methods
-
Dyspnea / prevention & control
-
Electrocardiography
-
Emergency Medical Services / organization & administration
-
Emergency Treatment / methods
-
Exercise Therapy / methods
-
Fibrinolytic Agents / therapeutic use
-
Forecasting
-
General Practice / organization & administration
-
Heart Failure / complications
-
Heart Failure / physiopathology
-
Heart Failure / therapy
-
Hemodynamics / physiology
-
Hospitalization
-
Humans
-
Hyperglycemia / complications
-
Hyperglycemia / therapy
-
Long-Term Care
-
Myocardial Infarction / complications
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / therapy*
-
Myocardial Reperfusion / methods
-
Out-of-Hospital Cardiac Arrest / diagnosis
-
Out-of-Hospital Cardiac Arrest / therapy
-
Pain / prevention & control
-
Percutaneous Coronary Intervention / methods
-
Platelet Aggregation Inhibitors / therapeutic use
-
Risk Assessment
-
Risk Reduction Behavior
-
Time-to-Treatment
Substances
-
Antifibrinolytic Agents
-
Cardiotonic Agents
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors